Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.

Viral immunology - 1 Apr 2013

Tamminen Kirsi, Huhti Leena, Vesikari Timo, Blazevic Vesna

Abstract excerpt

Noroviruses (NoVs) are one of the leading causes of acute nonbacterial gastroenteritis in humans of all ages. In the 1990s, NoV genotype GII-4 became responsible for the majority of NoV sporadic gastroenteritis cases and outbreaks worldwide. Vaccine development against NoV GII-4 is underway. At the same time, there is concern of new emerging NoV genotypes, such as GII-12, which has been recently associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caliciviridae Infections
Share to Cross Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Immune Tolerance

Share to Mice, Inbred BALB C

Share to Norovirus

Share to Viral Vaccines

Source

Identifiers

PMID: 23438469
DOI: 10.1089/vim.2012.0082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.PMID 23438469Read ↗

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.Semantic proximity Read ↗

Chimeric GII.4 Norovirus Virus-Like-Particle-Based Vaccines Induce Broadly Blocking Immune ResponsesSemantic proximity Read ↗

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.Semantic proximity Read ↗

Characterization of the homo- and heterotypic immune responses after natural norovirus infection.Semantic proximity Read ↗

Variable and conserved B cell epitopes of GII.4 human noroviruses.Semantic proximity Read ↗

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.Semantic proximity Read ↗

Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients.Semantic proximity Read ↗

Norovirus-Specific Memory T Cell Responses in Adult Human DonorsSemantic proximity Read ↗

Production, characterization and immunogenicity of P particles derived from norovirus GII.4 genotype 2004 variant.Semantic proximity Read ↗

Immune Imprinting Drives Human Norovirus Potential for Global Spread.Semantic proximity Read ↗

Norovirus GII.4 Strain Antigenic VariationSemantic proximity Read ↗

Manipulation of immunodominant variable epitopes of norovirus capsid protein elicited cross-blocking antibodies to different GII.4 variants despite the low potency of the polyclonal sera.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.